VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EVGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EVGNEvogene Ltd.
$0.27$3M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEVGNQuarterly Financials

Evogene Ltd. (EVGN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Evogene Ltd. (EVGN) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

EVGN Income Statement

Quarterly statement

EVGN Income Statement

Evogene Ltd. (EVGN) annual income statement — 14-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue347K334K314K312K884K2.44M1.61M1.74M605K4.19M578K3.77M654K641K660K466K312K237K311K151K
Revenue Growth %-60.75%-86.33%-80.51%-82.07%46.12%-41.67%178.72%-53.81%-7.49%553.67%-12.42%708.37%109.62%170.46%112.22%208.61%131.11%-28.83%-11.4%-52.22%
Cost of Goods Sold355K130K2.28M157K136K1.61M755K1.04M336K310K398K511K461K322K364K120K262K163K267K101K
COGS % of Revenue102.31%38.92%727.39%50.32%15.38%66.04%46.87%59.89%55.54%7.4%68.86%13.57%70.49%50.23%55.15%25.75%83.97%68.78%85.85%66.89%
Gross Profit-8K204K-1.97M155K748K830K856K698K269K3.88M180K3.26M193K319K296K346K50K74K44K50K
Gross Margin %-2.31%61.08%-627.39%49.68%84.62%33.96%53.13%40.11%44.46%92.6%31.14%86.43%29.51%49.77%44.85%74.25%16.03%31.22%14.15%33.11%
Gross Profit Growth %-101.07%-75.42%-330.14%-77.79%178.07%-78.61%375.56%-78.56%39.38%1116.3%-39.19%841.04%286%331.08%572.73%592%614.29%19.35%780%-79.25%
Operating Expenses2.43M3.35M3.24M2.88M3.82M4.96M5.42M6.62M4.9M7.97M7.81M7.44M8.09M7.12M4.08M7.44M8.06M8.13M8.74M8.61M
OpEx % of Revenue701.15%1004.19%1032.48%922.76%432.01%202.78%336.62%380.34%809.59%190.12%1350.87%197.48%1237.61%1109.98%617.88%1597.21%2582.37%3429.96%2809%5699.34%
Selling, General & Admin1.21M1.54M1.2M1.5M1.5M1.94M2.02M3.31M2.01M2.65M2.26M2.38M2.73M2.31M5.59M2.45M2.64M2.5M4.74M2M
SG&A % of Revenue348.13%462.57%380.89%479.17%169.46%79.34%125.51%190.4%332.4%63.15%391.52%63.07%416.67%361.15%846.97%525.11%846.15%1056.12%1523.47%1327.15%
Research & Development1.23M1.84M1.83M1.38M2.32M3.21M3.4M3.31M2.88M4.8M5.54M5.06M5.37M4.8M1.99M5M5.42M5.63M4M6.6M
R&D % of Revenue353.03%550.6%581.85%440.71%262.56%131.26%211.11%189.94%476.36%114.58%959.34%134.4%820.95%748.83%301.21%1072.1%1736.22%2373.84%1285.53%4372.19%
Other Operating Expenses0-30K219K9K0-191K005K519K0000-1000K00000
Operating Income-2.44M-3.15M-5.21M-2.72M-3.07M-4.13M-4.57M-5.92M-4.63M-4.09M-7.63M-4.18M-7.9M-6.8M-3.78M-7.1M-8.01M-8.05M-8.69M-8.56M
Operating Margin %-703.46%-943.11%-1659.87%-873.08%-347.4%-168.82%-283.49%-340.23%-765.12%-97.52%-1319.72%-111.04%-1208.1%-1060.22%-573.03%-1522.96%-2566.35%-3398.73%-2794.86%-5666.23%
Operating Income Growth %20.51%23.65%-14.12%53.99%33.66%-0.98%40.13%-41.53%41.41%39.88%-101.69%41.06%1.32%15.63%56.49%17.05%-7.53%-28.69%-21.11%-54.08%
EBITDA-2.29M-2.95M-4.95M-2.44M-2.83M-3.55M-3.97M-5.71M-4.3M-3.42M-6.96M-3.52M-7.25M-6.16M-3.14M-6.45M-7.39M-7.37M-8.14M-8.01M
EBITDA Margin %-660.52%-882.63%-1576.11%-783.01%-319.68%-145.13%-246.68%-328.22%-710.58%-81.5%-1205.02%-93.5%-1109.17%-960.22%-475.91%-1384.55%-2369.87%-3111.39%-2617.36%-5303.31%
EBITDA Growth %18.9%16.89%-24.53%57.22%34.26%-3.87%42.94%-62.15%40.74%44.52%-121.74%45.41%1.89%16.53%61.41%19.43%-7.6%-29.39%-24.27%-65.63%
D&A (Non-Cash Add-back)149K202K263K281K245K579K593K209K330K671K663K661K647K641K641K645K613K681K552K548K
EBIT-2.44M-2.02M-6.72M-2.27M-2.9M-2.52M-3.13M-3.86M-4.46M-3.68M-8.12M-3.75M-7.51M-6.49M-7.11M-6.9M-7.56M-8.01M-8.85M-8.18M
Net Interest Income972K-2.71M-169K12K-393K1.14M4.58M-821K97K241K287K320K144K-230K6K-61K-1.71M-1.05M602K221K
Interest Income1.14M1.17M181K465K235K1.6M4.73M2.07M194K407K358K429K391K308K169K194K444K41K938K380K
Interest Expense168K3.88M350K453K628K464K144K2.89M97K166K71K109K247K538K163K255K2.15M1.09M336K159K
Other Income/Expense850K-2.76M-126K-4K-457K1.14M4.57M-827K77K241K287K320K144K-230K6K-61K-1.71M-1.05M602K221K
Pretax Income-1.59M-5.91M-5.34M-2.73M-3.53M-2.99M2K-6.75M-4.55M-3.85M-7.34M-3.86M-7.76M-7.03M-3.78M-7.16M-9.72M-9.1M-8.09M-8.34M
Pretax Margin %-458.5%-1768.26%-1700%-874.36%-399.1%-122.3%0.12%-387.76%-752.4%-91.77%-1270.07%-102.55%-1186.09%-1096.1%-572.12%-1536.05%-3114.1%-3841.35%-2601.29%-5519.87%
Income Tax04K01K1K07K1K1K0-4K-5K21K-45K45K5K38K2K-6K8K
Effective Tax Rate %0%-0.07%0%-0.04%-0.03%0%350%-0.01%-0.02%0%0.05%0.13%-0.27%0.64%-1.19%-0.07%-0.39%-0.02%0.07%-0.1%
Net Income-1.77M-5.87M-5.31M3.87M-4.46M-2.59M427K-7.63M-5.42M-3.86M-6.6M-3.98M-7.02M-6.27M-3M-6.54M-8.82M-8.28M-7.37M-7.61M
Net Margin %-509.51%-1757.49%-1690.76%1241.67%-504.75%-105.85%26.51%-438.51%-895.7%-92.2%-1142.04%-105.76%-1073.85%-978.32%-454.24%-1404.29%-2827.24%-3491.56%-2370.1%-5039.74%
Net Income Growth %60.38%-126.9%-1343.33%150.77%17.66%33.03%106.47%-91.52%22.84%38.4%-120.18%39.12%20.38%24.22%59.33%14.01%-42.05%-25.34%9.25%-59.01%
Net Income (Continuing)-1.59M-5.91M-5.34M-2.73M-3.53M-2.99M-5K-6.75M-4.55M-3.85M-7.34M-3.86M-7.78M-6.98M-3.82M-7.16M-9.75M-9.11M-8.08M-8.34M
Discontinued Operations-176K14K-16K1000K-1000K00-1000K-1000K00000000000
Minority Interest9.06M10.54M12.06M16.11M15.93M16.04M16.29M16.58M16.87M17.09M16.63M17.35M16.82M6.41M6.86M7.72M8.45M9.2M9.77M10.07M
EPS (Diluted)-0.14-0.60-0.610.44-0.62-0.380.06-1.31-1.06-0.76-1.30-0.81-1.55-1.51-0.07-0.16-0.24-0.22-0.18-0.19
EPS Growth %77.42%-57.89%-1071.34%133.59%41.51%50%104.83%-61.73%31.61%49.67%-1688.17%-406.25%-545.83%-586.36%59.61%15.79%-60%-29.41%25%-5.56%
EPS (Basic)-0.14-0.60-0.610.44-0.62-0.380.06-1.31-1.06-0.76-1.30-0.81-1.55-1.51-0.07-0.16-0.24-0.22-0.18-0.19
Diluted Shares Outstanding12.2M9.74M8.72M8.72M7.23M6.8M6.8M5.81M5.09M5.06M5.06M4.89M4.52M4.15M41.23M41.22M41.2M41.19M41.18M40.85M
Basic Shares Outstanding12.2M9.74M8.72M8.72M7.23M6.8M6.8M5.81M5.09M5.06M5.06M4.89M4.52M4.15M41.23M41.22M41.2M41.19M41.18M40.85M
Dividend Payout Ratio--------------------